Guide on Patent Sequence Listing Preparation
Biotechnology invention entails gene mutation, gene sequencing, and gene regulation in the domain. Antibodies, genetically modified organisms, and biomarkers require sequencing genes, amino acids, and nucleotide bases to change the genetic makeup and produce modified (improved) live organisms. The process of entering the components of each item in the given format as prescribed by the patent office is known as Sequence listing. Patent Sequence Listing Requirements ● All patent applications must adhere to the Patent Office's rules. ● The USPTO guidelines define that all of the components should be written uniformly (US CFR 1.821-1.825). ● All DNA sequences with ten or more nucleotide bases and any unbranched known amino acid sequences with four or more amino acids should be provided. ● Whether stated in claims or descriptions, all sequences should be listed, with the claims sequence taking precedence. ● In all sequence listings, “SEQ ID NO:” identifies the gene or protein. ● A sequence ID number is required for each sequence. Why should you list in sequence?